Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
TherapeuticsMD, Inc.
TXMD
$1.82
Name : TherapeuticsMD, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $21,007,468.00
EPSttm : -0.04
finviz dynamic chart for TXMD
TherapeuticsMD, Inc.
$1.82
4.31%
$0.075
TXMD — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.23

Margin Of Safety %

-18

Put/Call OI Ratio

0.01

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

1.74

Target Price

5

Analyst Recom

1

Performance Q

-16.35

Upside

-114.9%

Beta

0.64

Ticker: TXMD



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-12TXMD2.020.010.20640
2026-10-13TXMD1.9650.010.20640
2026-10-14TXMD1.960.010.00644
2026-10-15TXMD1.9250.010.03646
2026-10-16TXMD1.90.010.00677
2026-10-19TXMD1.840.010.00676
2026-10-20TXMD1.910.010.00796
2026-10-21TXMD1.87210.010.00796
2026-10-22TXMD1.850.010.00796
2026-10-23TXMD1.80.010.00816
2026-10-26TXMD1.810.010.00816
2026-10-27TXMD1.79990.010.00816
2026-10-28TXMD1.790.010.00816
2026-10-29TXMD1.80.010.00816
2026-10-30TXMD1.80670.010.00816
2026-11-02TXMD1.79430.010.00843
2026-11-03TXMD1.790.010.00843
2026-11-04TXMD1.810.010.00843
2026-11-05TXMD1.720.010.00843
2026-11-06TXMD1.6950.010.00845
2026-11-09TXMD1.690.010.00905
2026-11-10TXMD1.740.010.00905
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-12TXMD2.02- - -
2026-10-13TXMD1.96- - -
2026-10-14TXMD1.96- - -
2026-10-15TXMD1.92- - -
2026-10-16TXMD1.90- - -
2026-10-19TXMD1.85- - -
2026-10-20TXMD1.85- - -
2026-10-21TXMD1.91- - -
2026-10-22TXMD1.90- - -
2026-10-23TXMD1.77- - -
2026-10-26TXMD1.82- - -
2026-10-27TXMD1.80- - -
2026-10-28TXMD1.82- - -
2026-10-29TXMD1.81- - -
2026-10-30TXMD1.80- - -
2026-11-02TXMD1.81- - -
2026-11-03TXMD1.81- - -
2026-11-04TXMD1.82- - -
2026-11-05TXMD1.71- - -
2026-11-06TXMD1.69- - -
2026-11-09TXMD1.69- - -
2026-11-10TXMD1.74- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-12TXMD0.00-0.760.22
2026-10-13TXMD0.00-0.760.22
2026-10-14TXMD0.00-0.760.22
2026-10-15TXMD0.00-0.760.22
2026-10-16TXMD0.00-0.760.22
2026-10-19TXMD0.00-0.760.22
2026-10-20TXMD0.00-0.760.22
2026-10-21TXMD0.00-0.760.22
2026-10-22TXMD0.00-0.760.22
2026-10-23TXMD0.00-0.760.22
2026-10-26TXMD0.00-0.760.22
2026-10-27TXMD0.00-0.760.23
2026-10-28TXMD0.00-0.760.23
2026-10-29TXMD0.00-0.760.23
2026-10-30TXMD0.00-0.760.23
2026-11-02TXMD0.00-0.770.23
2026-11-03TXMD0.00-0.770.23
2026-11-05TXMD0.00-0.770.23
2026-11-06TXMD0.00-0.770.23
2026-11-09TXMD0.00-0.610.23
2026-11-10TXMD0.00-0.610.23
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.61

Beta

0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

1.42

Quality Score

31

Growth Score

35

Sentiment Score

10

Actual DrawDown %

95.4

Max Drawdown 5-Year %

-98.1

Target Price

5

P/E

Forward P/E

PEG

P/S

6.16

P/B

0.74

P/Free Cash Flow

6.45

EPS

-0.02

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.64

Relative Volume

0.35

Return on Equity vs Sector %

-27.1

Return on Equity vs Industry %

-7.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ TXMD Healthcare
$1.74
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
18/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
7/10
RSI
37.8
Range 1M
27.9%
Sup Dist
4.6%
🚀
Momentum Growth
Ride accelerating trends
N/A
19 /100
WEAK
Momentum
6/25
Growth
4/30
Estimates
0/20
Inst/Vol
1/15
Options
8/10
EPS Yr
0%
EPS NY
0%
52W%
23.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +63.9% upside
Quality
5/30
Valuation
15/30
Growth
0/25
Stability
6/10
LT Trend
1/5
Upside
+63.9%
Quality
31
MoS
-18%
Click a card to see score breakdown Full Analysis →
TXMD — P/E HistoricalDrug Manufacturers - Specialty & Generic
TherapeuticsMD, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
TXMD

Latest News

—
Caricamento notizie per TXMD…
stock quote shares TXMD – TherapeuticsMD, Inc. Stock Price stock today
news today TXMD – TherapeuticsMD, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXMD – TherapeuticsMD, Inc. yahoo finance google finance
stock history TXMD – TherapeuticsMD, Inc. invest stock market
stock prices TXMD premarket after hours
ticker TXMD fair value insiders trading